LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev President and CEO Ibraheem (Ibs) Mahmood has been named one of the PharmaVOICE 100 most inspiring people in the life sciences industry. DrugDev is a leading provider of technology-driven solutions that help investigators, sponsors and CROs do more trials together.
The PharmaVOICE 100 is an annual compilation of individuals recognized for their positive contributions to the global industry. The panel of expert judges selected Ibs Mahmood for his vision and successful strategy to push far more medicines through the development process by guiding pharma to leverage technology to improve the cost and effectiveness of clinical trials. Since joining DrugDev in 2011, Ibs has grown the company from a handful of people to a world-class team – including recent acquisitions of CFS Clinical and TrialNetworks – backed by Invesco Perpetual.
Help employers find you! Check out all the jobs and post your resume.
